Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil

被引:10
|
作者
Ishida, Kaoru [1 ]
Ito, Chie [1 ]
Ohmori, Yukimi [1 ]
Kume, Kohei [1 ,2 ]
Sato, Kei A. [1 ]
Koizumi, Yuka [1 ]
Konta, Akari [1 ]
Iwaya, Takeshi [1 ]
Nukatsuka, Mamoru [3 ]
Kobunai, Takashi [3 ]
Takechi, Teiji [3 ]
Nishizuka, Satoshi S. [1 ,2 ,4 ]
机构
[1] Iwate Med Univ, Dept Surg, Sch Med, Mol Therapeut Lab, Morioka, Iwate 0208505, Japan
[2] Iwate Med Univ, Inst Biomed Sci, Div Biomed Res & Dev, Morioka, Iwate 0208505, Japan
[3] Taiho Pharmaceut Co Ltd, Translat Res Lab, Tokushima, Tokushima 7710194, Japan
[4] George Mason Univ, Inst Adv Biomed Res, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
GASTRIC-CANCER; ADAPTIVE RESISTANCE; PIK3CA MUTATION; TUMOR-CELLS; POTENT; GDC-0941; IDENTIFICATION; CHEMOTHERAPY; SURGERY;
D O I
10.1038/s41598-017-02548-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Drug-tolerant cancer cell subpopulations are responsible for relapse after chemotherapy. By continuously exposing the gastric cancer cell line MKN45 to 5-FU for > 100 passages, we established a 5-fluorouracil (5-FU)-tolerant line, MKN45/5FU. Orthotopic xenografts of MKN45/5FU cells in the stomach of nude mice revealed that these cells had a high potential to metastasize to sites such as the liver. Levels of phosphorylated phosphatidylinositide 3-kinase (PI3K) increased both in 5-FU-tolerant subpopulations according to the 5-FU dose, and in gastric submucosal orthotopic xenografts of MKN45/5FU cells. Sequential administration of 5-FU and a PI3K inhibitor, GDC-0941, targeted the downstream ribosomal S6 kinase phosphorylation to significantly suppress 5-FU-tolerant subpopulations and tumor propagation of orthotopic MKN45/5FU xenografts. These results suggest that administration of 5-FU followed by GDC-0941 may suppress disease relapse after 5-FU-based gastric cancer chemotherapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Phosphatidylethanolamine binding protein 1 enhances sensitivity of gastric cancer cell to 5-fluorouracil via inhibition of cell proliferation, migration and invasion
    Lin, Mengxin
    Lin, Xiaoyan
    Huang, Xiaobing
    Liu, Qing
    Wu, Riping
    Wang, Xinli
    Zhong, Dongta
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (12) : 2583 - 2590
  • [22] Dual inhibitor of PI3K and mTOR (NVP-BEZ235) augments the efficacy of fluorouracil on gastric cancer chemotherapy
    Li, Liangqing
    Zhang, Shengwei
    Xie, Diya
    Chen, Hui
    Zheng, Xuelan
    Pan, Dun
    ONCOTARGETS AND THERAPY, 2018, 11 : 6111 - 6118
  • [23] Knockdown of LINC02465 Suppresses Gastric Cancer Cell Growth and Metastasis Via PI3K/AKT Pathway
    Han, Liang
    Hao, Yanping
    Wang, Jianhua
    Wang, Zhengjiang
    Yang, Hongmei
    Wu, Xudong
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2019, 30 (01) : 19 - 28
  • [24] LHPP suppresses gastric cancer progression via the PI3K/AKT/mTOR signaling pathway
    Wang, Danfang
    Li, Jianhui
    Li, Wenhan
    JOURNAL OF CANCER, 2022, 13 (14): : 3584 - 3592
  • [25] The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
    Han, Anna
    Liu, Taorui
    Du, Pan
    Wang, Mengying
    Liu, Jiajing
    Chen, Liyan
    MOLECULAR CARCINOGENESIS, 2024, 63 (04) : 688 - 700
  • [26] Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways
    Zhang, Zhenzhen
    Yu, Weixing
    Zheng, Min
    Liao, Xinhua
    Wang, Jichuang
    Yang, Dayun
    Lu, Wenxian
    Wang, Long
    Zhang, Sheng
    Liu, Hekun
    Zhou, Xiao Zhen
    Lu, Kun Ping
    MOLECULAR CARCINOGENESIS, 2019, 58 (08) : 1450 - 1464
  • [27] Sodium cantharidinate suppresses human osteosarcoma MG-63 cell proliferation and induces cell cycle arrest by inhibition of PI3K/AKT activation
    Kong, Da-Liang
    Liu, Yang
    Wang, Jing-Ying
    Liu, Gong
    Zhang, Ming-Lei
    ONCOLOGY REPORTS, 2019, 41 (02) : 1351 - 1358
  • [28] PAX3 silencing suppresses gastric cancer proliferation and angiogenesis via MET/PI3K signaling
    Lv, W. L.
    Hu, Y. Y.
    Li, Z. N.
    Zhang, W.
    Pan, Q.
    NEOPLASMA, 2020, 67 (02) : 304 - 311
  • [29] PI3K p110α inhibition sensitizes cervical cancer cells with aberrant PI3K signaling activation to PARP inhibitor BMN673
    Cao, Penglong
    Wang, Yingxin
    Lv, Yunyi
    Jiang, Nan
    Zhong, Lin
    Ma, Xiaolu
    Xiao, Xiaoguang
    Ding, Dapeng
    Gu, Juebin
    Lin, Lin
    Li, Shijun
    ONCOLOGY REPORTS, 2019, 42 (05) : 2097 - 2107
  • [30] Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells
    Li, Hongyu
    Hu, Jing
    Wu, Shuhong
    Wang, Li
    Cao, Xiaobo
    Zhang, Xiaoshan
    Dai, Bingbing
    Cao, Mengru
    Shao, Ruping
    Zhang, Ran
    Majidi, Mourad
    Ji, Lin
    Heymach, John V.
    Wang, Michael
    Pan, Shiyang
    Minna, John
    Mehran, Reza J.
    Swisher, Stephen G.
    Roth, Jack A.
    Fang, Bingliang
    ONCOTARGET, 2016, 7 (03) : 3548 - 3558